×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

  • Gurus
  • Other
  • VIVO CAPITAL, LLC (Data extracted from 13F, 13D, 13G and Form 4)

VIVO CAPITAL, LLC

AUM: $5.81 B
13-F Portfolio Value: $1.10 B
Last 13-F Filed: Q2 2026
Concentration in top 10: 52.41%
Filter by:
Quarter to View:
Stock Company % Portfolio Shares Held Market Value Change in Shares % Change Quarter End Price Source
PRAXPraxis Precision Medicines8.29%271,116$90,766,926-67,779-20%$334.7913F
ERASErasca Inc6.9%4,127,412$75,614,188-8,024,068-66.03%$18.3213F
TNGXTango Therapeutics Inc3.94%1,379,769$43,131,579-775,011-35.97%$31.2613F
DBVTDBV Technologies SA2.76%1,844,758$30,254,031-822,811-30.84%$16.413F
SABSSAB Biotherapeutics Inc2.6%7,299,909$28,469,645-4,120,091-36.08%$3.913F
CMPXCompass Therapeutics Inc1.55%7,757,060$16,987,961-1,788,406-18.74%$2.1913F
UNCYUnicycive Therapeutics0.24%550,000$2,579,500-1,239,916-69.27%$4.6913F
KTTAPasithea Therapeutics Corp0.02%465,471$239,904-1,634,529-77.83%$0.5213F